Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Emily Garnett, 34, is a mom, wife and lawyer turned writer and podcast host living with metastatic breast cancer near New York City.
Two androgen receptor inhibitors improved survival by 33% in men with metastatic prostate cancer that responds to hormone therapy.
Even cancer that doesn’t affect the bones directly can contribute to bone problems.
Robert Ginyard, 57, lives in Baltimore with his wife and two children.
Task force says some women can benefit from risk-reducing drugs like tamoxifen, but women at average risk should not take them.
A large analysis finds hormone replacement therapy increases the risk about twice as much as previously thought.
Large international study sees no detrimental outcomes for mothers or babies.
Mental health care before cancer treatment is associated with higher death rates for those with kidney, prostate or bladder cancer.
Brain fog can have many causes including cancer itself and different types of treatment.
Darolutamide delays metastasis and reduces the risk of death in men with high-risk prostate cancer.
These men lived for a median of 30 months compared to 26 months for white men.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.